Precigen, Inc. (PGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Precigen, Inc. on January 16, 2025. The report addresses a specific regulatory event regarding the company's listing status on the Nasdaq Global Select Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance and listing compliance matter.
Material Changes and Events
- Nasdaq Compliance Restoration: The Company previously received notice on November 1, 2024, of non-compliance with Nasdaq Listing Rule 5450(a)(1) (the "Bid Price Rule") due to a minimum bid price below $1.00 for 30 consecutive business days.
- Resolution: On January 16, 2025, Nasdaq notified the Company that its common stock closed at or above $1.00 per share for the 10 consecutive business days ending January 15, 2025.
- Outcome: The Company has regained compliance with the Bid Price Rule, and the matter is now closed.
Guidance, Outlook, and Risks
The filing contains no financial guidance, management commentary on future operations, or discussion of new risks or contingencies beyond the resolution of the listing deficiency.
Key Facts for Investor Verification
- Verify the current trading price of PGEN to ensure continued compliance with the $1.00 minimum bid price requirement.
- Confirm that no further correspondence from Nasdaq regarding listing standards has been issued since January 16, 2025.
- Review the company's most recent 10-K or 10-Q filings for financial performance data, as this 8-K contains no financial statements.